Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Hochradel Shane J. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Operations Officer Shane J. Hochradel received an award of 87,719 restricted stock units, each representing the right to receive one share of common stock. These RSUs vest in roughly equal installments on March 13, 2027, 2028 and 2029, conditioned on his continued service. Following this compensation-related grant, his reported holdings from this award total 87,719 units.
Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, sold 25,000 shares of common stock in an open-market transaction at $24.00 per share. The sale was made under a Rule 10b5-1 trading plan adopted on 03/04/2026. After this transaction, he directly holds 1,103,816 shares, so the sale represents a relatively small portion of his overall stake.
ALHC filed a Form 144 reporting proposed sales and recent dispositions of its common stock. The filing lists 75,000 shares tied to a stock bonus (vesting date 10/06/2014) and records three sales by Joseph Konowiecki of 25,000 shares each on 06/11/2026, 06/18/2026, and 06/26/2026 with gross amounts of $525,000, $550,000, and $600,000 respectively.
Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, reported an open-market sale of 25,000 shares of Common Stock at $23.00 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on 03/04/2026, indicating it was pre-arranged. After the sale, he directly owns 1,128,816 shares, so the transaction represents a relatively small portion of his overall holdings.
ALHC submitted Form 144 reporting insider sales of Common stock by Joseph Konowiecki. The filing lists two sale notices: 06/11/2026 for 25,000 shares and 06/18/2026 for 25,000 shares. The broker listed is Merrill Lynch at 101 S Rodeo Drive, Beverly Hills.
Alignment Healthcare executive reports planned stock sale. EVP of Corporate Affairs Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare, Inc. common stock in an open-market transaction at $22.00 per share. Following this sale, he directly holds 1,153,816 shares. A footnote states the transaction was carried out under a Rule 10b5-1 trading plan adopted on 03/04/2026, indicating the sale was pre-arranged rather than timed discretionarily.
ALHC reports a Form 144 notice for a proposed sale of 25,000 common shares by Joseph Konowiecki.
The filing lists the proposed sale date as 06/11/2026 and an aggregate sale value of $525,000. It also shows a stock bonus of 75,000 shares vested on 10/06/2014 and lists 550,000 shares outstanding as of 06/18/2026.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock at a weighted-average price of $19.5475 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on May 22, 2025. After this sale, she directly holds 947,313 shares, indicating a large remaining ownership position.
Alignment Healthcare, Inc. Chief Medical Officer Hyong Kim reported an open-market sale of common stock. On June 12, 2026, Kim sold 35,951 shares at a weighted-average price of $19.8589 per share under a pre-arranged Rule 10b5-1 plan adopted on March 13, 2026.
After this transaction, Kim directly holds 331,750 shares of Alignment Healthcare common stock. The filing shows a single net-sell transaction with no derivative exercises or gifts disclosed in this report.
ALHC filed a Form 144 notice indicating proposed sales of Common stock consisting of 35,951 shares tied to restricted stock units granted 03/13/2026. The filing lists a prior sale by Hyong J Kim of 18,404 shares on 03/18/2026 for $328,327.36.
The filing is a regulatory notice of intended resale by an issuer/holder under applicable resale rules; timing and distribution mechanics are included in the filing headings.